Elevance Health (ELV)

Total Liabilities

$83.01B

Quarterly · Period ending: · USD

ELV logo

ELV Total Liabilities

Latest reported$83.01B
ELV Quarterly Total Liabilities ($3.92B → $83.01B)
High-resolution chart · PNG

ELV total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Elevance Health Total Liabilities — Quarterly (USD)
Period endingTotal Liabilities (USD)
83,007,000,000
81,416,000,000
81,785,000,000
77,468,000,000
78,667,000,000
78,087,000,000
77,097,000,000
75,463,000,000
72,654,000,000
70,691,000,000
71,184,000,000
69,523,000,000
71,939,000,000
70,856,000,000
71,580,000,000
66,425,000,000
66,983,000,000
65,010,000,000
64,455,000,000
61,332,000,000
62,252,000,000
61,051,000,000
61,765,000,000
55,077,000,000
52,653,000,000
53,521,000,000
50,706,000,000
46,526,000,000
46,477,000,000
45,058,000,000
44,525,000,000
43,929,000,000
45,351,000,000
45,642,400,000
46,288,000,000
44,956,800,000
42,361,600,000
41,805,900,000
42,851,600,000
41,286,700,000
39,655,700,000
39,829,000,000
40,311,600,000
38,673,700,000
39,099,500,000
41,201,200,000
41,211,700,000
37,425,000,000
37,764,200,000
37,926,700,000
37,340,200,000
34,809,300,000
35,455,400,000
35,079,800,000
35,090,600,000
35,152,700,000
32,001,400,000
30,891,200,000
28,968,100,000
28,875,000,000
28,831,800,000
26,695,900,000
26,939,900,000
26,354,300,000
26,670,700,000
26,369,500,000
26,661,700,000
27,262,100,000
26,630,100,000
27,091,400,000
27,906,800,000
26,971,500,000
28,085,300,000
29,721,400,000
30,051,600,000
29,069,600,000
29,225,800,000
29,205,300,000
28,349,800,000
26,999,100,000
27,340,800,000
26,854,000,000
27,252,800,000
26,412,100,000
20,620,900,000
21,139,600,000
20,487,200,000
20,279,400,000
7,335,800,000
7,095,400,000
7,574,400,000
7,409,000,000
7,352,200,000
7,174,600,000
7,030,900,000
7,077,000,000
6,909,900,000
4,410,700,000
4,277,000,000
4,277,100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.